info@scandibio.com
Toggle menu
About Us
Our Science
Scientific rationale
The Team
Clinical Studies
Phase I/II: SERINE
Phase I: METABOLIC COFACTORS
Phase II: NAFLD
Phase II: AD/PD
Phase II: COVID-19
Phase III: COVID-19
Publications
News
Contact
AD/PD
ScandiBio Therapeutics
→
AD/PD
AD/PD
Phase II-NEUROLOGICAL DISEASES
